MYOS RENS

MYOS NASDAQ
1.300
+0.075
+6.12%
After Hours: 1.150 -0.15 -11.54% 18:58 05/24 EDT
Open
1.230
Prev Close
1.225
High
1.310
Low
1.230
Volume
12.68K
Avg Vol (3M)
41.60K
52 Week High
2.500
52 Week Low
1.040
% Turnover
0.14%
Market Cap
11.92M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
MORE >

Recently

Name
Price
%Change